MFSD2A overexpression inhibited HCC cell proliferation, migration, invasion, and EMT in vitro, and reduced tumor growth in vivo by inhibiting TGF-β-mediated Smad signaling (Xiao et al., 2025). The gene discussed is TGFB1; the disease is neoplasm.